Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Adipsin preserves beta cells in diabetic mice and associates with protection from type 2 diabetes in humans.

Gómez-Banoy N, Guseh JS, Li G, Rubio-Navarro A, Chen T, Poirier B, Putzel G, Rosselot C, Pabón MA, Camporez JP, Bhambhani V, Hwang SJ, Yao C, Perry RJ, Mukherjee S, Larson MG, Levy D, Dow LE, Shulman GI, Dephoure N, Garcia-Ocana A, Hao M, Spiegelman BM, Ho JE, Lo JC.

Nat Med. 2019 Nov;25(11):1739-1747. doi: 10.1038/s41591-019-0610-4. Epub 2019 Nov 7.

PMID:
31700183
2.

Sex Differences in Cardiometabolic Traits and Determinants of Exercise Capacity in Heart Failure With Preserved Ejection Fraction.

Lau ES, Cunningham T, Hardin KM, Liu E, Malhotra R, Nayor M, Lewis GD, Ho JE.

JAMA Cardiol. 2019 Oct 30. doi: 10.1001/jamacardio.2019.4150. [Epub ahead of print]

PMID:
31664435
3.

Sex Differences in Circulating Biomarkers of Cardiovascular Disease.

Lau ES, Paniagua SM, Guseh JS, Bhambhani V, Zanni MV, Courchesne P, Lyass A, Larson MG, Levy D, Ho JE.

J Am Coll Cardiol. 2019 Sep 24;74(12):1543-1553. doi: 10.1016/j.jacc.2019.06.077.

PMID:
31537263
4.

Intramyocardial Triglycerides Among Women With vs Without HIV: Hormonal Correlates and Functional Consequences.

Toribio M, Neilan TG, Awadalla M, Stone LA, Rokicki A, Rivard C, Mulligan CP, Cagliero D, Fourman LT, Stanley TL, Ho JE, Triant VA, Burdo TH, Nelson MD, Szczepaniak LS, Zanni MV.

J Clin Endocrinol Metab. 2019 Dec 1;104(12):6090-6100. doi: 10.1210/jc.2019-01096.

PMID:
31393564
5.

Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study.

Bethea ED, Gaj K, Gustafson JL, Axtell A, Lebeis T, Schoenike M, Turvey K, Coglianese E, Thomas S, Newton-Cheh C, Ibrahim N, Carlson W, Ho JE, Shah R, Nayor M, Gift T, Shao S, Dugal A, Markmann J, Elias N, Yeh H, Andersson K, Pratt D, Bhan I, Safa K, Fishman J, Kotton C, Myoung P, Villavicencio MA, D'Alessandro D, Chung RT, Lewis GD.

Lancet Gastroenterol Hepatol. 2019 Oct;4(10):771-780. doi: 10.1016/S2468-1253(19)30240-7. Epub 2019 Jul 26.

PMID:
31353243
6.

Differential Clinical Profiles, Exercise Responses, and Outcomes Associated With Existing HFpEF Definitions.

Ho JE, Zern EK, Wooster L, Bailey CS, Cunningham T, Eisman AS, Hardin KM, Zampierollo GA, Jarolim P, Pappagianopoulos PP, Malhotra R, Nayor M, Lewis GD.

Circulation. 2019 Jul 30;140(5):353-365. doi: 10.1161/CIRCULATIONAHA.118.039136. Epub 2019 May 28.

PMID:
31132875
7.

Immune Correlates of Diffuse Myocardial Fibrosis and Diastolic Dysfunction Among Aging Women With Human Immunodeficiency Virus.

Zanni MV, Awadalla M, Toribio M, Robinson J, Stone LA, Cagliero D, Rokicki A, Mulligan CP, Ho JE, Neilan AM, Siedner MJ, Triant VA, Stanley TL, Szczepaniak LS, Jerosch-Herold M, Nelson MD, Burdo TH, Neilan TG.

J Infect Dis. 2019 May 17. pii: jiz184. doi: 10.1093/infdis/jiz184. [Epub ahead of print]

PMID:
31100122
8.

Reply: Galectin-3: A Pathophysiological Background Index or an Emerging Prognostic Biomarker in Heart Failure?

Ghorbani A, Ho JE.

J Am Coll Cardiol. 2019 Apr 16;73(14):1875-1876. doi: 10.1016/j.jacc.2019.02.016. No abstract available.

PMID:
30975312
9.

Galectin-3 Is Associated With Stage B Metabolic Heart Disease and Pulmonary Hypertension in Young Obese Patients.

Gopal DM, Ayalon N, Wang YC, Siwik D, Sverdlov A, Donohue C, Perez A, Downing J, Apovian C, Silva V, Panagia M, Kolachalama V, Ho JE, Liang CS, Gokce N, Colucci WS.

J Am Heart Assoc. 2019 Apr 2;8(7):e011100. doi: 10.1161/JAHA.118.011100.

10.

Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes.

Ghorbani A, Bhambhani V, Christenson RH, Meijers WC, de Boer RA, Levy D, Larson MG, Ho JE.

J Am Coll Cardiol. 2018 Dec 25;72(25):3246-3254. doi: 10.1016/j.jacc.2018.09.076.

PMID:
30573026
11.

Author Correction: Genome-wide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular disease.

Yao C, Chen G, Song C, Keefe J, Mendelson M, Huan T, Sun BB, Laser A, Maranville JC, Wu H, Ho JE, Courchesne P, Lyass A, Larson MG, Gieger C, Graumann J, Johnson AD, Danesh J, Runz H, Hwang SJ, Liu C, Butterworth AS, Suhre K, Levy D.

Nat Commun. 2018 Sep 18;9(1):3853. doi: 10.1038/s41467-018-06231-z.

12.

Genome-wide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular disease.

Yao C, Chen G, Song C, Keefe J, Mendelson M, Huan T, Sun BB, Laser A, Maranville JC, Wu H, Ho JE, Courchesne P, Lyass A, Larson MG, Gieger C, Graumann J, Johnson AD, Danesh J, Runz H, Hwang SJ, Liu C, Butterworth AS, Suhre K, Levy D.

Nat Commun. 2018 Aug 15;9(1):3268. doi: 10.1038/s41467-018-05512-x. Erratum in: Nat Commun. 2018 Sep 18;9(1):3853.

13.

β-Blockers After Inotropes in Acute Heart Failure-When Is the Right Time?

Ho JE.

Can J Cardiol. 2018 Sep;34(9):1102-1103. doi: 10.1016/j.cjca.2018.06.002. Epub 2018 Jun 5. No abstract available.

PMID:
30033081
14.

Temporal Trends in the Incidence of and Mortality Associated With Heart Failure With Preserved and Reduced Ejection Fraction.

Tsao CW, Lyass A, Enserro D, Larson MG, Ho JE, Kizer JR, Gottdiener JS, Psaty BM, Vasan RS.

JACC Heart Fail. 2018 Aug;6(8):678-685. doi: 10.1016/j.jchf.2018.03.006. Epub 2018 Jul 11.

15.

The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF.

Savji N, Meijers WC, Bartz TM, Bhambhani V, Cushman M, Nayor M, Kizer JR, Sarma A, Blaha MJ, Gansevoort RT, Gardin JM, Hillege HL, Ji F, Kop WJ, Lau ES, Lee DS, Sadreyev R, van Gilst WH, Wang TJ, Zanni MV, Vasan RS, Allen NB, Psaty BM, van der Harst P, Levy D, Larson M, Shah SJ, de Boer RA, Gottdiener JS, Ho JE.

JACC Heart Fail. 2018 Aug;6(8):701-709. doi: 10.1016/j.jchf.2018.05.018. Epub 2018 Jul 11.

16.

Protein Biomarkers of Cardiovascular Disease and Mortality in the Community.

Ho JE, Lyass A, Courchesne P, Chen G, Liu C, Yin X, Hwang SJ, Massaro JM, Larson MG, Levy D.

J Am Heart Assoc. 2018 Jul 13;7(14). pii: e008108. doi: 10.1161/JAHA.117.008108.

17.

High-Sensitivity Troponin and Heart Failure With Preserved Ejection Fraction-Balancing P Values With Prior Knowledge and Common Sense-Reply.

de Boer RA, Nayor M, Ho JE.

JAMA Cardiol. 2018 Sep 1;3(9):892-893. doi: 10.1001/jamacardio.2018.1623. No abstract available.

PMID:
29926109
18.

Sex-specific associations of obesity and N-terminal pro-B-type natriuretic peptide levels in the general population.

Suthahar N, Meijers WC, Ho JE, Gansevoort RT, Voors AA, van der Meer P, Bakker SJL, Heymans S, van Empel V, Schroen B, van der Harst P, van Veldhuisen DJ, de Boer RA.

Eur J Heart Fail. 2018 Aug;20(8):1205-1214. doi: 10.1002/ejhf.1209. Epub 2018 Jun 1.

19.

Pulmonary Capillary Wedge Pressure Patterns During Exercise Predict Exercise Capacity and Incident Heart Failure.

Eisman AS, Shah RV, Dhakal BP, Pappagianopoulos PP, Wooster L, Bailey C, Cunningham TF, Hardin KM, Baggish AL, Ho JE, Malhotra R, Lewis GD.

Circ Heart Fail. 2018 May;11(5):e004750. doi: 10.1161/CIRCHEARTFAILURE.117.004750.

20.

A Meta-Analysis of Genome-Wide Association Studies of Growth Differentiation Factor-15 Concentration in Blood.

Jiang J, Thalamuthu A, Ho JE, Mahajan A, Ek WE, Brown DA, Breit SN, Wang TJ, Gyllensten U, Chen MH, Enroth S, Januzzi JL Jr, Lind L, Armstrong NJ, Kwok JB, Schofield PR, Wen W, Trollor JN, Johansson Å, Morris AP, Vasan RS, Sachdev PS, Mather KA.

Front Genet. 2018 Mar 23;9:97. doi: 10.3389/fgene.2018.00097. eCollection 2018.

21.

Sex Differences in Subclinical Coronary Atherosclerotic Plaque Among Individuals With HIV on Antiretroviral Therapy.

Foldyna B, Fourman LT, Lu MT, Mueller ME, Szilveszter B, Neilan TG, Ho JE, Burdo TH, Lau ES, Stone LA, Toribio M, Srinivasa S, Looby SE, Lo J, Fitch KV, Zanni MV.

J Acquir Immune Defic Syndr. 2018 Aug 1;78(4):421-428. doi: 10.1097/QAI.0000000000001686.

22.

Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update.

Suthahar N, Meijers WC, Silljé HHW, Ho JE, Liu FT, de Boer RA.

Theranostics. 2018 Jan 1;8(3):593-609. doi: 10.7150/thno.22196. eCollection 2018. Review.

23.

Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction.

de Boer RA, Nayor M, deFilippi CR, Enserro D, Bhambhani V, Kizer JR, Blaha MJ, Brouwers FP, Cushman M, Lima JAC, Bahrami H, van der Harst P, Wang TJ, Gansevoort RT, Fox CS, Gaggin HK, Kop WJ, Liu K, Vasan RS, Psaty BM, Lee DS, Hillege HL, Bartz TM, Benjamin EJ, Chan C, Allison M, Gardin JM, Januzzi JL Jr, Shah SJ, Levy D, Herrington DM, Larson MG, van Gilst WH, Gottdiener JS, Bertoni AG, Ho JE.

JAMA Cardiol. 2018 Mar 1;3(3):215-224. doi: 10.1001/jamacardio.2017.4987.

24.

Harnessing the Power of Pharmacometabolomics: The Metabolic Footprint of Statins.

Ho JE.

Circ Cardiovasc Genet. 2017 Dec;10(6). pii: e002014. doi: 10.1161/CIRCGENETICS.117.002014. No abstract available.

25.

Predictors and outcomes of heart failure with mid-range ejection fraction.

Bhambhani V, Kizer JR, Lima JAC, van der Harst P, Bahrami H, Nayor M, de Filippi CR, Enserro D, Blaha MJ, Cushman M, Wang TJ, Gansevoort RT, Fox CS, Gaggin HK, Kop WJ, Liu K, Vasan RS, Psaty BM, Lee DS, Brouwers FP, Hillege HL, Bartz TM, Benjamin EJ, Chan C, Allison M, Gardin JM, Januzzi JL Jr, Levy D, Herrington DM, van Gilst WH, Bertoni AG, Larson MG, de Boer RA, Gottdiener JS, Shah SJ, Ho JE.

Eur J Heart Fail. 2018 Apr;20(4):651-659. doi: 10.1002/ejhf.1091. Epub 2017 Dec 11.

26.

Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy.

Ho JE, Shi L, Day SM, Colan SD, Russell MW, Towbin JA, Sherrid MV, Canter CE, Jefferies JL, Murphy A, Taylor M, Mestroni L, Cirino AL, Sleeper LA, Jarolim P, Lopez B, Gonzalez A, Diez J, Orav EJ, Ho CY.

Open Heart. 2017 Nov 1;4(2):e000615. doi: 10.1136/openhrt-2017-000615. eCollection 2017.

27.

High-Sensitivity Troponin in the General Population: Time for a New Normal?

Ho JE.

J Am Coll Cardiol. 2017 Aug 1;70(5):569-571. doi: 10.1016/j.jacc.2017.06.015. No abstract available.

28.

Preclinical Alterations in Myocardial Microstructure in People with Metabolic Syndrome.

Ho JE, Rahban Y, Sandhu H, Hiremath PG, Ayalon N, Qin F, Perez AJ, Downing J, Gopal DM, Cheng S, Colucci WS.

Obesity (Silver Spring). 2017 Sep;25(9):1516-1522. doi: 10.1002/oby.21936. Epub 2017 Jul 24.

29.

Can Heart Failure With Preserved Ejection Fraction Shed Light on the Mortality-Readmissions Paradox?

Ho JE.

JACC Heart Fail. 2017 Jul;5(7):494-496. doi: 10.1016/j.jchf.2017.03.013. Epub 2017 May 10. No abstract available.

30.

Cardiometabolic Traits and Systolic Mechanics in the Community.

Ho JE, McCabe EL, Wang TJ, Larson MG, Levy D, Tsao C, Aragam J, Mitchell GF, Benjamin EJ, Vasan RS, Cheng S.

Circ Heart Fail. 2017 May;10(5). pii: e003536. doi: 10.1161/CIRCHEARTFAILURE.116.003536.

31.

The association of chronic kidney disease and microalbuminuria with heart failure with preserved vs. reduced ejection fraction.

Nayor M, Larson MG, Wang N, Santhanakrishnan R, Lee DS, Tsao CW, Cheng S, Benjamin EJ, Vasan RS, Levy D, Fox CS, Ho JE.

Eur J Heart Fail. 2017 May;19(5):615-623. doi: 10.1002/ejhf.778. Epub 2017 Feb 20.

32.

Biomarkers to identify and prevent new-onset heart failure in the community.

Meijers WC, de Boer RA, Ho JE.

Eur J Heart Fail. 2016 Nov;18(11):1351-1352. doi: 10.1002/ejhf.636. No abstract available.

33.

Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.

Hiremath P, Lawler PR, Ho JE, Correia AW, Abbasi SA, Kwong RY, Jerosch-Herold M, Ho CY, Cheng S.

Circ Heart Fail. 2016 Sep;9(9). pii: e003026. doi: 10.1161/CIRCHEARTFAILURE.116.003026.

34.

An exome array study of the plasma metabolome.

Rhee EP, Yang Q, Yu B, Liu X, Cheng S, Deik A, Pierce KA, Bullock K, Ho JE, Levy D, Florez JC, Kathiresan S, Larson MG, Vasan RS, Clish CB, Wang TJ, Boerwinkle E, O'Donnell CJ, Gerszten RE.

Nat Commun. 2016 Jul 25;7:12360. doi: 10.1038/ncomms12360.

35.

Response to Letter Regarding Article, "Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction".

Santhanakrishnan R, Wang N, Larson MG, Magnani JW, McManus DD, Lubitz SA, Ellinor PT, Cheng S, Vasan RS, Lee DS, Wang TJ, Levy D, Benjamin EJ, Ho JE.

Circulation. 2016 Jun 7;133(23):e692-3. doi: 10.1161/CIRCULATIONAHA.116.022835. No abstract available.

36.

Predicting Heart Failure With Preserved and Reduced Ejection Fraction: The International Collaboration on Heart Failure Subtypes.

Ho JE, Enserro D, Brouwers FP, Kizer JR, Shah SJ, Psaty BM, Bartz TM, Santhanakrishnan R, Lee DS, Chan C, Liu K, Blaha MJ, Hillege HL, van der Harst P, van Gilst WH, Kop WJ, Gansevoort RT, Vasan RS, Gardin JM, Levy D, Gottdiener JS, de Boer RA, Larson MG.

Circ Heart Fail. 2016 Jun;9(6). pii: e003116. doi: 10.1161/CIRCHEARTFAILURE.115.003116.

37.

Serial galectin-3 and future cardiovascular disease in the general population.

van der Velde AR, Meijers WC, Ho JE, Brouwers FP, Rienstra M, Bakker SJ, Muller Kobold AC, van Veldhuisen DJ, van Gilst WH, van der Harst P, de Boer RA.

Heart. 2016 Jul 15;102(14):1134-41. doi: 10.1136/heartjnl-2015-308975. Epub 2016 Apr 15.

38.

Racial Differences in Electrocardiographic Characteristics and Prognostic Significance in Whites Versus Asians.

Santhanakrishnan R, Wang N, Larson MG, Magnani JW, Vasan RS, Wang TJ, Yap J, Feng L, Yap KB, Ong HY, Ng TP, Richards AM, Lam CS, Ho JE.

J Am Heart Assoc. 2016 Mar 25;5(3):e002956. doi: 10.1161/JAHA.115.002956. Erratum in: J Am Heart Assoc. 2016 Jul;5(7). pii: e002058. doi: 10.1161/JAHA.116.002058.

39.

Metabolomic Profiles of Body Mass Index in the Framingham Heart Study Reveal Distinct Cardiometabolic Phenotypes.

Ho JE, Larson MG, Ghorbani A, Cheng S, Chen MH, Keyes M, Rhee EP, Clish CB, Vasan RS, Gerszten RE, Wang TJ.

PLoS One. 2016 Feb 10;11(2):e0148361. doi: 10.1371/journal.pone.0148361. eCollection 2016.

40.

Evaluation of a provocative dyspnea severity score in acute heart failure.

AbouEzzeddine OF, Lala A, Khazanie PP, Shah R, Ho JE, Chen HH, Pang PS, McNulty SE, Anstrom KJ, Hernandez AF, Redfield MM; NHLBI Heart Failure Clinical Research Network.

Am Heart J. 2016 Feb;172:34-41. doi: 10.1016/j.ahj.2015.10.009. Epub 2015 Oct 20.

41.

Galectin-3 Is Associated with Restrictive Lung Disease and Interstitial Lung Abnormalities.

Ho JE, Gao W, Levy D, Santhanakrishnan R, Araki T, Rosas IO, Hatabu H, Latourelle JC, Nishino M, Dupuis J, Washko GR, O'Connor GT, Hunninghake GM.

Am J Respir Crit Care Med. 2016 Jul 1;194(1):77-83. doi: 10.1164/rccm.201509-1753OC.

42.

Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction.

Santhanakrishnan R, Wang N, Larson MG, Magnani JW, McManus DD, Lubitz SA, Ellinor PT, Cheng S, Vasan RS, Lee DS, Wang TJ, Levy D, Benjamin EJ, Ho JE.

Circulation. 2016 Feb 2;133(5):484-92. doi: 10.1161/CIRCULATIONAHA.115.018614. Epub 2016 Jan 8.

43.

Circulating Galectin-3 Is Associated With Cardiometabolic Disease in the Community.

Nayor M, Wang N, Larson MG, Vasan RS, Levy D, Ho JE.

J Am Heart Assoc. 2015 Dec 31;5(1). pii: e002347. doi: 10.1161/JAHA.115.002347.

44.

Preclinical Systolic and Diastolic Dysfunctions in Metabolically Healthy and Unhealthy Obese Individuals.

Wang YC, Liang CS, Gopal DM, Ayalon N, Donohue C, Santhanakrishnan R, Sandhu H, Perez AJ, Downing J, Gokce N, Colucci WS, Ho JE.

Circ Heart Fail. 2015 Sep;8(5):897-904. doi: 10.1161/CIRCHEARTFAILURE.114.002026. Epub 2015 Jul 14.

45.

Erratum: Distinct metabolomic signatures are associated with longevity in humans.

Cheng S, Larson MG, McCabe EL, Murabito JM, Rhee EP, Ho JE, Jacques PF, Ghorbani A, Magnusson M, Souza AL, Deik AA, Pierce KA, Bullock K, O'Donnell CJ, Melander O, Clish CB, Vasan RS, Gerszten RE, Wang TJ.

Nat Commun. 2015 May 21;6:7317. doi: 10.1038/ncomms8317. No abstract available.

PMID:
25993905
46.

Distinct metabolomic signatures are associated with longevity in humans.

Cheng S, Larson MG, McCabe EL, Murabito JM, Rhee EP, Ho JE, Jacques PF, Ghorbani A, Magnusson M, Souza AL, Deik AA, Pierce KA, Bullock K, O'Donnell CJ, Melander O, Clish CB, Vasan RS, Gerszten RE, Wang TJ.

Nat Commun. 2015 Apr 13;6:6791. doi: 10.1038/ncomms7791. Erratum in: Nat Commun. 2015;6:7317.

47.

Impaired right ventricular hemodynamics indicate preclinical pulmonary hypertension in patients with metabolic syndrome.

Gopal DM, Santhanakrishnan R, Wang YC, Ayalon N, Donohue C, Rahban Y, Perez AJ, Downing J, Liang CS, Gokce N, Colucci WS, Ho JE.

J Am Heart Assoc. 2015 Mar 10;4(3):e001597. doi: 10.1161/JAHA.114.001597.

48.

Soluble ST2 testing in the general population.

Ho JE, Sritara P, deFilippi CR, Wang TJ.

Am J Cardiol. 2015 Apr 2;115(7 Suppl):22B-5B. doi: 10.1016/j.amjcard.2015.01.036. Epub 2015 Jan 23. Review.

PMID:
25665763
49.

The MESA heart failure risk score: can't we do more?

Ho JE, Magnani JW.

Heart. 2015 Jan;101(1):7-9. doi: 10.1136/heartjnl-2014-306459. Epub 2014 Nov 11. No abstract available.

PMID:
25387949
50.

Biomarkers of cardiovascular stress and subclinical atherosclerosis in the community.

Gopal DM, Larson MG, Januzzi JL, Cheng S, Ghorbani A, Wollert KC, Kempf T, D'Agostino RB, Polak JF, Ramachandran VS, Wang TJ, Ho JE.

Clin Chem. 2014 Nov;60(11):1402-8. doi: 10.1373/clinchem.2014.227116. Epub 2014 Sep 18.

Supplemental Content

Support Center